What makes us different? Read our Declaration of Journalistic Independence Home | About Natural News | Contact Us | Write for Natural News
Mevacor

Why Merck Lost Its 3rd Bid to Sell Mevacor Over the Counter

Monday, February 04, 2008 by: Teri Lee Gruss (see all articles by this author)
| Key concepts: Mevacor, Merck and statins

Want stories like this e-mailed to you? Click here for free email alerts

Email this article to a friend Printable Version

Personal Health Solutions from NaturalNews

Replace your toxic laundry detergent with natural laundry soap that grows on trees! (Popular solution!)
This top "underground" natural health newsletter brings you amazing new natural cures each month. Save $100!
How to treat and cure over 100 health conditions using little-known health secrets
How to halt type-2 diabetes with nutritional therapy - over 50% cure rate proven in studies
End cravings with this guide to natural appetite suppressants (Download edition available.)
How to blend nutritious meals in minutes with Adams' Superfood smoothie recipes (Delicious!)
Breakthrough LED lighting technology prevents global warming, saves 90% on your lighting bill

Browse more health books...
Shop our eco-friendly products...

All sales help fund NaturalNews operations.
(NaturalNews) An expert panel working with the FDA recently voted 10 to 2 against approving Merck’s statin drug Mevacor for over-the-counter (OTC) sales. The FDA could potentially ignore this recent vote and approve Merck’s request but this is not a likely scenario considering the results of a recent Merck sponsored study designed to assess the public’s ability to appropriately decide if the 20mg dose of Mevacor would benefit them.

This is the third time in 7 years that Merck has attempted to gain FDA approval to sell its statin Mevacor OTC.

Dr. Sidney Wolf, director of the Health Research Group at Public Citizen, participated in the hearings and said that the Merck SELECT study “shows that up to 93 percent of the people deciding on their own to purchase Mevacor should not take the drug”. According to Dr. Wolf, overall an average of 75% of the study participants inappropriately self diagnosed a need for statins.

Most media coverage of the SELECT study quoted that 25% of the 1,500 study participants incorrectly self-diagnosed a need for statins but when Dr. Wolf, along with other experts independently examined the data they found:

“21.5 percent of people deciding on their own to purchase OTC Mevacor had a less risky cardiovascular risk profile than the threshold (5 percent or higher risk of coronary heart disease (CHD) in 10 years) for which there is evidence that the drug would be of any benefit to them”.

“29 percent of women who made the assessment in the SELECT study, and they were candidates for the drug, were actually younger than 55”.

Data from the SELECT study also found that "almost 30% of people previously diagnosed with heart disease, diabetes or stroke would buy OTC Mevacor". According to the FDA this group of people need to be under a physician’s care.

The results of this study show that an alarming portion of the population would needlessly put themselves at risk for the adverse side effects of statins including depletion of coenzyme Q10, muscle cell damage, liver damage, cognitive dysfunction, birth defects and long term risk for cancer.

Dr. Wolf included in his testimony the comments of Dr. Frank Davidoff, former Editor of the Annals of Internal Medicine: “In effect, approving statins for OTC primary prevention would amount to a huge uncontrolled experiment, in which neither the benefit nor the risk side of the equation are known”. Dr. Davidoff was a former member of the committee that evaluated Merck’s bid for OTC approval of Mevacor and was “one of the 20 members opposing the OTC switch in 2005”.

In contrast, a Merck spokesperson optimistically said that the latest study shows “overwhelmingly favorable results that consumers can self-assess and make the appropriate decision to purchase over-the-counter Mevacor”. Merck representatives argued that OTC availability of Mevacor would offer a “major public health benefit”.

Current conventional risk factors for heart disease include smoking, low HDL, high blood pressure and a relative who developed cardiovascular disease (CVD) at an early age. The medical profession is advised to look for the presence of at least one of these risk factors before prescribing statins.

Total cholesterol and LDL, the very lipids that statins lower, are not independent risk factors for CVD. You will not find them on the American Heart Association list of CVD risk factors. Irresponsible advertising (both to the public and the medical profession) perpetuate the notion that lowering total cholesterol and LDL will prevent a large portion of the population from dying of CVD.

The “Lipid hypothesis” of heart disease fails to acknowledge a large body of scientific evidence that shows that half of people that suffer heart attacks have "normal" or low levels of total cholesterol and LDL. Nor has the “Lipid Hypothesis” been successfully tested in the female and elderly population, groups commonly prescribed statins.

At a time when there is increasing evidence that the incidence of adverse and serious side effects in statin users are under reported, to say that the OTC sale of Mevacor would be a benefit to public health is extraordinarily irresponsible.

Joel Kauffman, PhD in Organic Chemistry from MIT and author of Malignant Medicine, writes that "The benefits of the statin drugs in reducing mortality are exaggerated, being only about 0.3% per year from the most favorable trials reported. This is not as great as the benefits of omega-3 supplements. Indeed lovastatin (Mevacor) increased the all-cause mortality rate in its two reported trials”.

According to Public Citizen, in 2006 Mevacor sales fell to “less than 0.25 percent of the overall market for lovastatin because of generic competition. OTC approval would temporarily grant exclusive OTC sales status to Merck for three years.”

Based on Merck’s own study results, OTC statins would put a large segment of our population at risk of very serious side effects without any health benefits. And yet the company continues to say (with a straight face) that Mevacor OTC would provide a major public health benefit, a claim that even the FDA apparently won't back.

Hats off to Dr. Sidney Wolf at Public Citizen and Dr. Joel Kauffman for providing the public with unbiased information regarding the misuse of statins.

References:

Testimony before the FDA Endocrinologic/Metabolic and Non-Prescription Drugs Advisory Committees, December 13, 2007 by Sidney M. Wolfe, M.D. Director, Health Research Group at Public Citizen

Testimony on the public health dangers of making lovastatin (MEVACOR) available over-the-counter (HRG Publication #1829)

((http://www.citizen.org/publications/rel...)

Malignant Medicine, Joel Kauffman PhD, p. 101

About the author

Teri Lee Gruss, MS Human Nutrition


###

Related Articles

Despite the claims of the mainstream media, Lesco and other statins are not magic bullets for cholesterol

FDA Moves to Shut Down Red Yeast Rice Distributors Online

Statin drugs expose patients to dangerous, debilitating side effects

Popular Topics:

Mevacor, Merck, statins, Diabetes, High Blood Pressure, Breast cancer, Prostate cancer, Heart disease, Depression, High cholesterol, Osteoporosis, Vaccines, Autism, ADHD, Infertility, Weight loss, Cancer, Alzheimer's, Trans fats, Acrylamides, Fluoride, Mercury

Take Action: Support NaturalNews.com

Email this article to a friend

Share this article on: NewsVine | digg | del.icio.us

Permalink to this article: http://www.NaturalNews.com/022587.html

Reprinting this article: Non-commercial OK, cite NaturalNews.com with clickable link.

Receive our Natural Health Newsletter for FREE

Subscribe now (it's free!) to win. We randomly choose a subscriber each month to send $100 in eco-home products or a RealGoods.com gift certificate (our choice). Plus, you'll receive FREE news, articles and action alerts from NaturalNews.com editors and join over 800,000 monthly readers who report extraordinary health improvements after becoming a subscriber!
  • Receive breaking news alerts on natural health solutions, renewable energy, the environment, global warming and more.
  • Receive a free instant download of our $29 Secret Sources guide that reveals top sources for little-known health and diet solutions.
Your Email Address:
Free Subscription Code:
Enter the numbers you see:
100% free of charge. Unsubscribe anytime.
Absolutely no spam. We respect your email privacy.

Recommended Special Report:

Seven Words that can Change the World
by Joseph R. Simonetta

Read this special report now...

"Seven Words That Can Change the World reveals the astonishing, simple truths that have the power to forever transform our world for the better while freeing our minds from the enslavement of limiting beliefs. This is not a text for the simple-minded; it is a guiding philosophy for the mindful, intelligent few who are wise enough to seek out -- and recognize -- the higher simplicities of truly purposeful living." - Mike Adams, the Health Ranger, editor of NaturalNews.com

More on NaturalNews.com:

Streaming Health Ranger Videos
CounterThink Cartoons
FREE Special Reports
Podcasts

Also Posted Today

Review: Organic Food Bar Offers Exclusive Discount to Natural News Readers on Their Best Food Bars

Indole-3-Carbinol Nutrient in Broccoli Protects the Heart, Balances Cholesterol

The HPV Vaccine: Herd Immunity or Human Sacrifice?

Lead in Diabecon? An Ayurvedic Anti-Diabetes Herbal Complex Gets the Test

Scientists Agree That EMFs Pose a Threat to Your Health

Beat Disease With Juice Feasting!

NEW 6-CD audio set reveals amazing new protocol for reversing cancer, diabetes, obesity, heart disease and more. Click to learn more.

Own Health Ranger Report Podcasts on Audio CD

Own the first 8 Health Ranger Report audio programs on 6 CDs. Covers weight loss, ADHD, vaccinations, processed meats, bone health and more. Click to learn more.

Featured Videos

Short clip on Aspartame
A short clip on aspartame from the documentary All Jacked Up.
Click here to view now...

Exclusive video on Aspartame
The dangers of aspartame! Exclusive interview footage from Cori Brackett of Sweet Remedy.
Click here to view now...

Exclusive Footage from All Jacked Up!
See interview footage featuring the Health Ranger in the upcoming junk food film, All Jacked Up.
Click here to view now...

Drug Ad Parody
See the Health Ranger's satire parody of Merck's cholesterol drug ad.
Click here to view now...

Free Health Reports!

Amazon Herb Company review
The pH Nutrition Guide to Acid / Alkaline Balance
Pet Food Ingredients Revealed! (shocking)
Medicine From Fish
The Water Cure
The Healing Power of Sunlight and Vitamin D

Featured CounterThink Cartoons

HPV Vaccine Texas Tyranny


The Plan for the Food Supply


Fidozac: Antidepressant Drugs for Dogs


Health Product Companies We Recommend

Read recommendations on supplement companies, health food manufacturers and personal care product makers that you can trust. Our 100% independent review list tells you who to trust and who to avoid in the natural health industry. Click to read.
This site is part of the Natural News Network © 2008 All Rights Reserved. Privacy | Terms All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing International, LTD. is not responsible for content written by contributing authors. Truth Publishing sells no health or nutritional products and earns no money from health product manufacturers or promoters. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. Truth Publishing assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published here. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.